Covered recipient · General Payments record
NEIL TOURNOUX
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2022–2023
$621.80
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $222.75 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $88.74 | 1 |
| Alkermes, Inc. | $62.35 | 3 |
| Validus Pharmaceuticals LLC | $25.19 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.50 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.61 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $14.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $15.46 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022931435 | CMS |
| Alkermes, Inc. | $18.95 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022931437 | CMS |
| Alkermes, Inc. | $27.94 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022931439 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $14.36 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034345211 | CMS |
| Neurocrine Biosciences, Inc. | $88.74 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052242435 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.50 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015565127 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.61 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056032149 | CMS |
| Validus Pharmaceuticals LLC | $25.19 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991142177 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.